Age-Related Clinical Characteristics, Inflammatory Features, Phenotypes, and Treatment Response in Asthma

医学 哮喘 优势比 过敏性 内科学 前瞻性队列研究 人口 儿科 免疫学 环境卫生
作者
Ji Wang,Xin Zhang,Li Zhang,Ying Liu,Gang Wang,Hong Ping Zhang,Gang Wang,De Ying Kang,Brian G. Oliver,Hua Wan,Vanessa M. McDonald,Alan Hsu,Dan Liu,Wei Min Li,Surinder S. Birring,Gang Wang
出处
期刊:The Journal of Allergy and Clinical Immunology: In Practice [Elsevier BV]
卷期号:11 (1): 210-219.e3 被引量:56
标识
DOI:10.1016/j.jaip.2022.09.029
摘要

Background Emerging evidence suggests that aging affects asthma outcomes, but the mechanism remains largely unexplored. Objective To explore age-related clinical characteristics, inflammatory features, phenotypes, and treatment response in asthma. Methods This was a prospective cohort study of asthmatic patients with a 12-month follow-up in a real-world setting. Clinical inflammatory and phenotypic characteristics, future risk for exacerbations, and treatment response were assessed across different age groups (young was defined as age 18 to 39 years; middle-aged, 40 to 64 years; and elderly, 65 years or older). Results Compared with young (n = 106) and middle-aged (n = 179) asthmatic patients, elderly patients (n = 55) had worse airway obstruction, more comorbidities including chronic obstructive pulmonary disease and diabetes, less atopy, and lower levels of IgE and FeNO, and were more likely to have late-onset and fixed airflow obstruction asthma and a reduced risk for having type 2 profile asthma. Levels of IFN-gamma, IL-17A, and IL-8 in induced sputum were significantly increased in elderly asthmatic patients (all P < .05). Path analysis indicated that age directly and significantly led to future exacerbations in asthma, partially mediated by an upregulation of airway IFN-gamma. Moreover, elderly patients with asthma had a reduced treatment response (improvement in FEV1 of 12% or greater, or 200 mL, and a reduction in Borg scores of 1 or greater) (adjusted odds ratio = 0.11; 95% CI, 0.02-0.52; and adjusted odds ratio = 0.12; 95% CI, 0.03-0.49, respectively). Conclusions This study confirms that asthma in the elderly population represents a specific phenotype and indicates that aging can influence asthma in terms of clinical characteristics, inflammatory features, exacerbations, and treatment response. Emerging evidence suggests that aging affects asthma outcomes, but the mechanism remains largely unexplored. To explore age-related clinical characteristics, inflammatory features, phenotypes, and treatment response in asthma. This was a prospective cohort study of asthmatic patients with a 12-month follow-up in a real-world setting. Clinical inflammatory and phenotypic characteristics, future risk for exacerbations, and treatment response were assessed across different age groups (young was defined as age 18 to 39 years; middle-aged, 40 to 64 years; and elderly, 65 years or older). Compared with young (n = 106) and middle-aged (n = 179) asthmatic patients, elderly patients (n = 55) had worse airway obstruction, more comorbidities including chronic obstructive pulmonary disease and diabetes, less atopy, and lower levels of IgE and FeNO, and were more likely to have late-onset and fixed airflow obstruction asthma and a reduced risk for having type 2 profile asthma. Levels of IFN-gamma, IL-17A, and IL-8 in induced sputum were significantly increased in elderly asthmatic patients (all P < .05). Path analysis indicated that age directly and significantly led to future exacerbations in asthma, partially mediated by an upregulation of airway IFN-gamma. Moreover, elderly patients with asthma had a reduced treatment response (improvement in FEV1 of 12% or greater, or 200 mL, and a reduction in Borg scores of 1 or greater) (adjusted odds ratio = 0.11; 95% CI, 0.02-0.52; and adjusted odds ratio = 0.12; 95% CI, 0.03-0.49, respectively). This study confirms that asthma in the elderly population represents a specific phenotype and indicates that aging can influence asthma in terms of clinical characteristics, inflammatory features, exacerbations, and treatment response.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
yang发布了新的文献求助10
刚刚
1秒前
CodeCraft的应助被zr采纳,获得50
1秒前
莫妮卡卡完成签到,获得积分10
2秒前
科研通AI6.3的应助被大知闲闲采纳,获得10
2秒前
2秒前
Zz完成签到,获得积分10
2秒前
严大师完成签到,获得积分10
2秒前
wanci的应助被星空采纳,获得10
3秒前
等待蓝天发布了新的文献求助10
3秒前
木易发布了新的文献求助10
3秒前
黎小浩完成签到,获得积分10
4秒前
4秒前
深情安青的应助被调皮颜采纳,获得10
4秒前
Tao发布了新的文献求助10
4秒前
安安完成签到,获得积分20
5秒前
5秒前
5秒前
5秒前
失眠呆呆鱼完成签到 ,获得积分10
6秒前
杨梦珺发布了新的文献求助10
6秒前
6秒前
7秒前
负责母鸡完成签到 ,获得积分10
7秒前
7秒前
xingfangshu发布了新的文献求助10
7秒前
悲凉的友安完成签到,获得积分10
7秒前
kijc完成签到 ,获得积分10
9秒前
9秒前
Han完成签到,获得积分10
9秒前
烟花的应助被好天气采纳,获得10
10秒前
10秒前
wanna发布了新的文献求助10
11秒前
友亿完成签到 ,获得积分10
11秒前
11秒前
12秒前
anan发布了新的文献求助10
12秒前
泪了睡吧发布了新的文献求助30
12秒前
JXY189发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186480
求助须知:如何正确求助?哪些是违规求助? 9574861
关于积分的说明 21838499
捐赠科研通 7784154
什么是DOI,文献DOI怎么找? 3434775
关于科研通互助平台的介绍 2559164
邀请新用户注册赠送积分活动 2481565